Requiring a physician or podiatrists' name on scripts for controlled substances has caused patients to experience delays in having their pain medications filled. PAs hold their own DEA licenses, have completed the required pharmacology training, and have access to the Prescription Monitoring Program. Removing this requirement only increases access to care.